Zoe M. Weinstein MD, MS

Assistant Professor, General Internal Medicine

801 Massachusetts Ave | (617) 414-7399
Zoe Weinstein
Sections

General Internal Medicine

Centers

Clinical Addiction Research and Education Unit

Biography

Zoe M. Weinstein MD,MS, is a general internist and a graduate of the Boston University Addiction Medicine Fellowship. Her clinical work and research are focused on long-term Office-Based Addiction Treatment (OBAT) with buprenorphine, as well as the integration of addiction treatment with primary care and inpatient medical care. She is the director of Boston Medical Center’s Addiction Consult Service and Associate Director of the Grayken Addiction Medicine Fellowship.

Education

Medicine-Internal, MD, University of California San Francisco, 2011

Psychology, BA, Columbia University, 2006

Publications

Published on 9/1/2021

Montalvo C, von Horn A, Lane CE, Weinstein ZM, Sharma M, Suzuki J. Precipitated Withdrawal, Delirium, and Cerebellar Stroke: The Pharmacology of Buprenorphine Induction in Non-pharmaceutical Fentanyl and the Neuropsychiatric Manifestations of Cerebellar Stroke. Harv Rev Psychiatry. 2021 Sep-Oct 01; 29(5):370-377. PMID: 34524778.

Published on 8/29/2021

Harris MT, Seliga RK, Fairbairn N, Nolan S, Walley AY, Weinstein ZM, Turnbull J. Outcomes of Ottawa, Canada's Managed Opioid Program (MOP) where supervised injectable hydromorphone was paired with assisted housing. Int J Drug Policy. 2021 Aug 29; 98:103400. PMID: 34469781.

Published on 4/28/2021

Harris MTH, Peterkin A, Bach P, Englander H, Lapidus E, Rolley T, Weimer MB, Weinstein ZM. Correction to: Adapting inpatient addiction medicine consult services during the COVID-19 pandemic. Addict Sci Clin Pract. 2021 Apr 28; 16(1):25. PMID: 33910637.

Published on 4/20/2021

Roy PJ, Price R, Choi S, Weinstein ZM, Bernstein E, Cunningham CO, Walley AY. Shorter outpatient wait-times for buprenorphine are associated with linkage to care post-hospital discharge. Drug Alcohol Depend. 2021 07 01; 224:108703. PMID: 33964730.

Published on 3/19/2021

Peterkin A, Davis CS, Weinstein Z. Permanent Methadone Treatment Reform Needed to Combat the Opioid Crisis and Structural Racism. J Addict Med. 2021 Mar 19. PMID: 33758114.

Published on 2/24/2021

Harris MTH, Peterkin A, Bach P, Englander H, Lapidus E, Rolley T, Weimer MB, Weinstein ZM. Adapting inpatient addiction medicine consult services during the COVID-19 pandemic. Addict Sci Clin Pract. 2021 02 24; 16(1):13. PMID: 33627183.

Published on 1/31/2021

Campbell CI, Saxon AJ, Boudreau DM, Wartko PD, Bobb JF, Lee AK, Matthews AG, McCormack J, Liu DS, Addis M, Altschuler A, Samet JH, LaBelle CT, Arnsten J, Caldeiro RM, Borst DT, Stotts AL, Braciszewski JM, Szapocznik J, Bart G, Schwartz RP, McNeely J, Liebschutz JM, Tsui JI, Merrill JO, Glass JE, Lapham GT, Murphy SM, Weinstein ZM, Yarborough BJH, Bradley KA. PRimary Care Opioid Use Disorders treatment (PROUD) trial protocol: a pragmatic, cluster-randomized implementation trial in primary care for opioid use disorder treatment. Addict Sci Clin Pract. 2021 01 31; 16(1):9. PMID: 33517894.

Published on 1/19/2021

Hagle HN, Martin M, Winograd R, Merlin J, Finnell DS, Bratberg JP, Gordon AJ, Johnson C, Levy S, MacLane-Baeder D, Northup R, Weinstein Z, Lum PJ. Dismantling racism against Black, Indigenous, and people of color across the substance use continuum: A position statement of the association for multidisciplinary education and research in substance use and addiction. Subst Abus. 2021; 42(1):5-12. PMID: 33465013.

Published on 12/15/2020

Peeler CE, Gorgy M, Sadlak N, Sathe S, Tamashunas N, Fiorello MG, Cabral H, Paasche-Orlow MK, Weinstein ZM. A Pilot Study of Automated Pupillometry in the Treatment of Opioid Use Disorder. J Addict Med. 2020 Dec 15; Publish Ahead of Print. PMID: 33323697.

Published on 12/8/2020

Komaromy M, Tomanovich M, Taylor JL, Ruiz-Mercado G, Kimmel SD, Bagley SM, Saia KM, Costello E, Park TW, LaBelle C, Weinstein Z, Walley AY. Adaptation of a System of Treatment for Substance Use Disorders During the COVID-19 Pandemic. J Addict Med. 2020 Dec 08. PMID: 33298750.

View full list of 30 publications.